Indian government may loosen clinical trial rules
ABSTRACT
The government of India may do an about-face on clinical trial rules put into place in 2013 and loosen restrictions for drugmakers.
Soumya Swaminathan, secretary of the Department of Health Research and director-general of the Indian Council of Medical Research, said drug testing in the country had suffered since the tighter rules were put into place and, as a result, fewer tests were taking place and no new drugs had been registered, according to a report by the New Indian Express.
She said under the planned rule change, new trials will be cleared by “local ethics committees” and would not need to be overseen by the Drug Controller General of India.
By-Matthew Driskill
0 Comments